Literature DB >> 23266229

Targeting the Wnt/frizzled signaling pathway after myocardial infarction: a new tool in the therapeutic toolbox?

Evangelos P Daskalopoulos1, Kevin C M Hermans, Ben J A Janssen, W Matthijs Blankesteijn.   

Abstract

Wnt/frizzled signaling in the adult heart is quiescent under normal conditions; however it is reactivated after myocardial infarction (MI). Any intervention at the various levels of this pathway can modulate its signaling. Several studies have targeted Wnt/frizzled signaling after MI with the majority of them indicating that the inhibition of the pathway is beneficial since it improves infarct healing and prevents heart failure. This suggests that blocking the Wnt/frizzled signaling pathway could be a potential novel therapeutic target to prevent the adverse cardiac remodeling after MI.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266229     DOI: 10.1016/j.tcm.2012.09.010

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  19 in total

Review 1.  Wnt/β-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target.

Authors:  Habib Haybar; Elahe Khodadi; Saeid Shahrabi
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

Review 2.  Cell-cell interaction in the heart via Wnt/β-catenin pathway after cardiac injury.

Authors:  Arjun Deb
Journal:  Cardiovasc Res       Date:  2014-03-03       Impact factor: 10.787

3.  Mechanoregulation of Myofibroblast Fate and Cardiac Fibrosis.

Authors:  Peter Kim; Nick Chu; Jennifer Davis; Deok-Ho Kim
Journal:  Adv Biosyst       Date:  2017-12-04

Review 4.  The role of Wnt regulation in heart development, cardiac repair and disease: A tissue engineering perspective.

Authors:  Aric Pahnke; Genna Conant; Locke Davenport Huyer; Yimu Zhao; Nicole Feric; Milica Radisic
Journal:  Biochem Biophys Res Commun       Date:  2015-11-26       Impact factor: 3.575

5.  Inhibition of Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways.

Authors:  Jeffrey Schmeckpeper; Amanda Verma; Lucy Yin; Farideh Beigi; Lunan Zhang; Alan Payne; Zhiping Zhang; Richard E Pratt; Victor J Dzau; Maria Mirotsou
Journal:  J Mol Cell Cardiol       Date:  2015-06-10       Impact factor: 5.000

6.  Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway.

Authors:  Jian Cao; Peter L Tsenovoy; Ellen A Thompson; John R Falck; Robert Touchon; Komal Sodhi; Rita Rezzani; Joseph I Shapiro; Nader G Abraham
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-02-09       Impact factor: 3.072

7.  UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine.

Authors:  André Uitterdijk; Kevin C M Hermans; Daphne P M de Wijs-Meijler; Evangelos P Daskalopoulos; Irwin K Reiss; Dirk J Duncker; W Matthijs Blankesteijn; Daphne Merkus
Journal:  Lab Invest       Date:  2015-12-14       Impact factor: 5.662

8.  Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis.

Authors:  David T Paik; Meena Rai; Sergey Ryzhov; Lehanna N Sanders; Omonigho Aisagbonhi; Mitchell J Funke; Igor Feoktistov; Antonis K Hatzopoulos
Journal:  Circ Res       Date:  2015-09-03       Impact factor: 17.367

Review 9.  Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.

Authors:  Robert G Gourdie; Stefanie Dimmeler; Peter Kohl
Journal:  Nat Rev Drug Discov       Date:  2016-06-24       Impact factor: 84.694

10.  Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity.

Authors:  Jingyi Yu; Marcus M Seldin; Kai Fu; Shen Li; Larry Lam; Ping Wang; Yijie Wang; Dian Huang; Thang L Nguyen; Bowen Wei; Rajan P Kulkarni; Dino Di Carlo; Michael Teitell; Matteo Pellegrini; Aldons J Lusis; Arjun Deb
Journal:  Circ Res       Date:  2018-04-24       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.